If you have been reading about melanocortin receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-10. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
These clotting mediators also provide a structural staging framework at the inflammatory tissue site in the form of a fibrin lattice – as would construction scaffolding at a construction site – for the purpose of aiding phagocytic debridement and wound repair later on. Some of the exuded tissue fluid is also funneled by lymphatics to the regional lymph nodes, flushing bacteria along to start the recognition and attack phase of the adaptive immune system.
The evidence is circumstantial, and though it seems to implicate Mundt, Leamas repeatedly rejects that conclusion, claiming that an important East German official could not have been a British agent without his knowledge. However, Fiedler is able to independently confirm Leamas' information and comes to the conclusion that Mundt, his supervisor, has indeed been a secret asset of British intelligence for many years. Mundt himself unexpectedly arrives at the compound and has both Leamas and Fiedler arrested for plotting against him. Once Fiedler explains his findings to his superiors, the tables are turned and Mundt is arrested. A secret tribunal is convened to try Mundt for espionage, with Leamas compelled to testify. Fiedler presents a strong case for Mundt being a paid double agent. However, Mundt's attorney uncovers several discrepancies in Leamas' transformation into an informant, suggesting that Leamas is a faux defector. Leamas' credibility collapses when Nan, who has been brought to East Germany for what she thought was a cultural exchange visit, is forced to testify at the tribunal and unwittingly reveals that she has been receiving payments from a British intelligence officer as Leamas had arranged. Faced with this testimony, Leamas reluctantly admits that he is indeed a British agent. Mundt is vindicated, and Fiedler is arrested as a complicit dupe. Leamas initially believes he has failed in his mission and fears severe retribution from Mundt.
The possibility of establishing a chronic viral infection was further demonstrated in Sendai virus-infected ovine fibroblasts. In nature, enzootic disease patterns suggest that the virus can be latent and can be cleared over the course of a year.
=== Legal status === In September 2023, the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended authorizing lebrikizumab (Ebglyss) for the treatment of atopic dermatitis. Lebrikizumab was authorized for medical use in the European Union in November 2023. In September 2023, the US Food and Drug Administration (FDA) declined to approve lebrikizumab due to certain findings during an inspection of a contract manufacturer, unrelated to the clinical trial data, safety, or label for lebrikizumab. Lebrikizumab was approved by the FDA in September 2024.
Sources: en.wikipedia.org
In a passage describing the challenges of "boiling an egg", for instance, the reader is not given any clue that the original Japanese text discussed a speciality of Kyoto-style cuisine called koya dofu (高野豆腐), a freeze dried tofu dish named after the Koyasan region from which it originates. In contrast to the symbolism of Kyoto-style cuisine as authentic Japanese fare, Tanizaki disparages Kobe as "foreign" including items like liver sausage from a German butcher. Of Tanazaki's characters, Louise, a prostitute involved with Kaname, is the most strongly associated with Kobe fare. Though Misako's consumption of the Kobe style food is alluded to from time to time, Misako herself is more clearly associated with the eastern Japanese fare of Tokyo.
==== Nigeria ==== In February 2021, Zipline announced a plan to construct three distribution centers in Kaduna State, Nigeria. These distribution centers would have ultra-cold storage that is capable of safely storing COVID-19 vaccines, for which health facilities in the state could then place on-demand orders without needing ultra-cold storage of their own. The state also intends to use Zipline's service to transport other health products, including blood, medication, and routine vaccines. In May 2021, Zipline announced a similar agreement with Cross River State. In February 2022, Zipline announced another agreement with Bayelsa State. The first hub opened in Kaduna state in an undisclosed location on June 4, 2022.
=== Phrixotoxin-1 === Mice that are injected with phrixotoxin-1 can experience numerous, transient, adverse cardiac reactions, such as premature ventricular beats, ventricular tachycardia, and atrio-ventricular blocks. Neurological effects observed are motor impairment and convulsions. These effects are seen following both intravenous and intracisternal injection, making it likely that phrixotoxin-1 crosses the blood brain barrier (Diochot 1999).
=== Biophysical carbon dioxide-concentrating mechanisms === This type of carbon dioxide-concentrating mechanism (CCM) relies on a contained compartment within the cell into which CO2 is shuttled, and where RuBisCO is highly expressed. In many species, biophysical CCMs are only induced under low carbon dioxide concentrations. Biophysical CCMs are more evolutionary ancient than biochemical CCMs. There is some debate as to when biophysical CCMs first evolved, but it is likely to have been during a period of low carbon dioxide, after the Great Oxygenation Event (2.4 billion years ago). Low CO2 periods occurred around 750, 650, and 320–270 million years ago.
== Pathophysiology == Scleroderma is characterised by increased synthesis of collagen (leading to the sclerosis), damage to small blood vessels, activation of T lymphocytes, and production of altered connective tissue. Its proposed pathogenesis is the following:
Sources: en.wikipedia.org
{\displaystyle {\begin{array}{rl}{\ce {H2A <=> HA^- + H+}}:&K_{1}={\frac {{\ce {[HA-] [H+]}}}{{\ce {[H2A]}}}}\\{\ce {HA- <=> A^2- + H+}}:&K_{2}={\frac {{\ce {[A^{2-}] [H+]}}}{{\ce {[HA-]}}}}\end{array}}}
30 June PAVN/VC mortar shells destroyed the Phuoc Long pagoda in Chanh Hiep, Bình Dương Province; one Buddhist monk was killed and ten persons wounded. Three members of the People's Self-Defense Force were kidnapped from Phu My, Biên Hòa Province. Two U.S. military policemen were shot and killed by an ARVN Lieutenant colonel during a conflict at a nightclub in Saigon.
== Enforcement == Multiple federal entities oversee enforcement of Stark Law. These include the Department of Justice, CMS, and the Department of Health and Human Services. In recent years, enforcement of Stark Law has become increasingly aggressive, largely as a result of the Patient Protection and Affordable Care Act and its amendments to the False Claims Act. 2014 saw some of the largest Stark Law violation settlements to date. On June 9, 2015, the Office of Inspector General issued a fraud alert targeting physician compensation arrangements with hospitals and health systems. Fines and settlements total in the billions of dollars.
=== Ribo-seq-like === Ribo-tRNA-seq has been developed to observe the role of tRNA more closely in translation. Similar to Ribo-seq, Ribo-tRNA-seq captures tRNA molecules in ribosomes for library preparation before sequencing.
In Staphylococcus aureus, IMPDH have been identified as a plasminogen-binding protein. Drosophila IMPDH has been demonstrated to act as a sequence-specific transcriptional repressor that can reduce the expression of histone genes and E2F. IMPDH localizes to the nucleus at the end of the S phase and nuclear accumulation is mostly restricted to the G2 phase. In addition, metabolic stress has been shown to induce the nuclear localization of IMPDH.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.